Clinical Trials Related to Acute Myeloid Leukemia

Related studies linked through entity extraction aliases.

Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Venetoclax + Azacitidine vs. Induction Chemotherapy in AML

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Status: RECRUITING
Phase: PHASE1/PHASE2

Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Status: TERMINATED
Phase: PHASE1

Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML

Status: COMPLETED
Phase: N/A

Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

Status: TERMINATED
Phase: PHASE3

Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia

Status: COMPLETED
Phase: NA

Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Status: RECRUITING
Phase: PHASE1/PHASE2

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Status: RECRUITING
Phase: PHASE1

A Study of BGB-11417 in Participants With Myeloid Malignancies

Status: RECRUITING
Phase: PHASE1/PHASE2

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Status: UNKNOWN
Phase: PHASE1/PHASE2

Trial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and Venetoclax

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia

Status: UNKNOWN
Phase: PHASE1/PHASE2

A Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)

Status: TERMINATED
Phase: PHASE1

Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Status: COMPLETED
Phase: NA

Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia

Status: COMPLETED
Phase: PHASE1/PHASE2

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Status: RECRUITING
Phase: PHASE1/PHASE2

PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML

Status: UNKNOWN
Phase: PHASE3